Elon Musk’s brain chip company Neuralink gets FDA approval for human trial

Neuralink, Elon Musk’s brain chip company, has announced that clinical trial recruitment will finally be open to the public following FDA-approved human trials.

Elon Musk’s company recently made some big announcements about its brain chip and people are curious to find out where it’s going.

The news comes weeks after Elon announced that Linda Yaccarino will be Twitter’s new CEO.

Business photo illustrations of Elon Musk
Photo illustration by Jakub Porzycki/NurPhoto via Getty Images

Clinical trial recruitment is coming soon

Recruitment for the brain chip clinical trials will eventually be public. The same was confirmed by Neuralink when they wrote: “Recruitment for our clinical trial is not yet open. We will be announcing more information on this soon!”

Interested parties can now register in their patient registry website. This will help you understand if you qualify for future exams.

All you have to do is answer certain questions, e.g. B. Your legal age, whether or not you are a permanent resident, and much more.

You will then be asked for your consent as well as personal and health information in the application.

What we know about Neuralink

The company hopes to use technology to help people with unmet medical needs. It is currently focused on giving people with quadriplegia the ability to control computers and cell phones with their minds.

Quadriplegia is a condition in which a person suffers from paralysis below the neck, including the hands and legs.

Neuralink hopes its technology can one day help people restore skills like vision, motor skills, speech and more.

Neuralink illustrations
Photo illustration by Jonathan Raa/NurPhoto via Getty Images

The FDA approves human trials

On May 26, Newuralink confirmed that the FDA had approved these studies.

In the tweet, the company wrote, “We are pleased to announce that we have received FDA approval to begin our first human clinical trial!”

“This is the result of the incredible work of the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” the statement continued.

Elon also congratulated the team while people wait and see how this technology will change the world.

The Post: Elon Musk’s Brain Chip Company Neuralink Receives FDA Approval for Human Trial appeared first on HITC.

Emma Bowman

Emma Bowman is a USTimeToday U.S. News Reporter based in London. His focus is on U.S. politics and the environment. He has covered climate change extensively, as well as healthcare and crime. Emma Bowman joined USTimeToday in 2023 from the Daily Express and previously worked for Chemist and Druggist and the Jewish Chronicle. He is a graduate of Cambridge University. Languages: English. You can get in touch with Emma Bowman by emailing EmmaBowman@ustimetoday.com.

Related Articles

Back to top button